Neoadjuvant Immunotherapy Plus Chemotherapy Shows Promise in LS-SCLC
Written by
American Journal Managed Care
Published
0
comments
0
min
The findings may inform future studies on the therapeutic strategy for patients with small cell lung cancer (SCLC).